Steven G. Smith

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Theodore W. Laetsch, Steven G. DuBois, Leo Mascarenhas et al. · The Lancet Oncology · 2018 · 536 citations · Full text

Tumoral Pathology, Medicine, Pathology +7

Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia

Steven G. Smith, Ruchong Chen, Melanie Kjarsgaard et al. · Journal of Allergy and Clinical Immunology · 2015 · 445 citations · Full text

Asthma, Group 2, Severe Asthma +9

Selective RET kinase inhibition for patients with RET-altered cancers

Vivek Subbiah, Vamsidhar Velcheti, Brian B. Tuch et al. · Annals of Oncology · 2018 · 422 citations · Full text

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 420 citations · Full text

Cyclosporine in severe childhood atopic dermatitis: A multicenter study

J. Berth‐Jones, A.Y. Finlay, Irshad Zaki et al. · Journal of the American Academy of Dermatology · 1996 · 198 citations

Drug Hypersensitivity, Allergy, Atopic Dermatitis +6